HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Squamous cell cancer cell lines: sensitivity to bleomycin and suitability for animal xenograft studies.

Abstract
Bleomycin (BLM) is a natural antibiotic, toxic to dividing cells (G2/M-phase), also proven effective in squamous cell carcinomas (SCC). We have clinically shown that a short-range beta-emitting radionuclide combined to bleomycin (In-111-BLMC) is a tumor-targeting agent in SCCs. With higher radionuclide activities it may be possible to develop a more effective agent, to be tested in animal studies. Using a 96-well clonogenic assay we investigated three SCC cell lines, grown in our own laboratory. IC20, IC50 and IC90 values for BLM were determined. The UT-SCC-12A and UT-SCC-12B cells were originated from a primary tumor and a metastasis of the same patient. UT-SCC-12A cells were also inoculated subcutaneously into nude mice and the tumor growth was analysed. The IC50 value for UT-SCC-19A cell line was 4.0 +/- 1.3 nM. UT-SCC-12A and UT-SCC-12B were both more resistant to BLM; IC50 values were 14.2 +/- 2.8 nM and 13.0 +/- 1.1 nM, respectively. Within 35 days the weight of nude mice increased 2.8 +/- 0.6g. At 25 and 35 days after tumor inoculations the tumor volumes were 111 +/- 51 mm3 and 874 +/- 577 mm3, respectively. The calculated doubling time was 3.86 +/- 0.76 days. SCC cell lines demonstrate different sensitivity to BLM. Our SCC tumor xenograft model showed a rapid growth proper for radiochemotherapeutic studies using In-111-BLMC. The uptake of In-111-BLMC in vivo has been directly proportional to proliferation activity, and the tumors with high binding capacity could be predicted from animal model dose calculations.
AuthorsH A Jääskelä-Saari, K J Kairemo, H A Ramsay, R Grénman
JournalActa oto-laryngologica. Supplementum (Acta Otolaryngol Suppl) Vol. 529 Pg. 241-4 ( 1997) ISSN: 0365-5237 [Print] Norway
PMID9288321 (Publication Type: Journal Article)
Chemical References
  • Antibiotics, Antineoplastic
  • Indium Radioisotopes
  • Organometallic Compounds
  • indium-bleomycin
  • Bleomycin
Topics
  • Animals
  • Antibiotics, Antineoplastic (therapeutic use)
  • Bleomycin (analogs & derivatives, therapeutic use)
  • Carcinoma, Squamous Cell (drug therapy, radiotherapy)
  • Combined Modality Therapy (methods)
  • Drug Screening Assays, Antitumor
  • Humans
  • Indium Radioisotopes (therapeutic use)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Mice, Nude
  • Neoplasm Transplantation
  • Organometallic Compounds (therapeutic use)
  • Transplantation, Heterologous
  • Tumor Cells, Cultured

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: